Teva (TEVA) and Active Biotech are set to initiate the third Phase III trial of their oral...

|About: Teva Pharmaceutical Indus... (TEVA)|By:, SA News Editor

Teva (TEVA) and Active Biotech are set to initiate the third Phase III trial of their oral Laquinimod treatment for relapsing remitting multiple sclerosis. Two previous trials have produced positive results. Teva also nominates former Bank Leumi CEO Galia Maor as a director.